WOCKPHARMA Wockhardt Ltd Other Situations Announcement 2024 - Volume Movement Clarified WOCKHARDT LTD. responded to BSE about increased trading volume, attributing it to a recent press release on their antibiotic MiqnafTM receiving favorable recommendations for treating pneumonia, but states no other significant announcement currently affecting stock behavior..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Wockhardt Ltd